The Next Generation of Biologics

Now Available: 2023 Biologics Symposium OnDemand 

If you were not able to attend The Next Generation of Biologics this year, you can now get all the presentations from the symposium delivered straight to your computer or mobile device! 

The 2023 Biologics Symposium OnDemand recording will feature the latest updates, insights, and unique perspectives from the leading names in orthobiologics. 

Symposium Co-Chairs:

Jason L. Dragoo, MD, FAAOS

Scott Rodeo, MD, FAAOS

Shane A. Shapiro, MD

Presentations

Introduction 

Jason L. Dragoo, MD, FAAOS

Professor and Vice Chair of Academic Affairs, Endowed Chair of Regenerative Medicine, University of Colorado

Session 1: Rules of Engagement

Moderator: Jason L. Dragoo, MD, FAAOS

Understanding the FDA Regulatory Pathways for Approval of Orthobiologic Products

Scott Bruder, MD, PhD

Founder and CEO, Bruder Consulting

Standards Needed for Bedside (Same Surgical Procedure) Orthobiologic Procedures

Shane A. Shapiro, MD

Medical Director, Regenerative Medicine Therapeutics Program, Mayo Clinic

Session 2: Point of Care Processing of Autologous Bone Marrow and Adipose Tissue

Moderator: Shane A. Shapiro, MD

Medical Director, Regenerative Medicine Therapeutics Program, Mayo Clinic

Part 1: Bone Marrow Aspirate

Standardized Cell Dosing of Bone Marrow Cells Using Optical Scanning

David C. Karli, MD, MBA

CEO, Greyledge Technologies

Automated Methods for Characterization of Cell Therapy Formulations

George F. Muschler, MD, FAAOS, FAOA, FORS, FAAAS

Professor of Orthopaedics and Biomedical Engineering, Director, Joint Preservation Center, Cleveland Clinic

Increase Yield of MSCs but Not WBCs in BMA Concentration

Michael R. Tucker, MD

Medical Business Development Manager, RegenLab USA LLC

Part 2: Adipose Tissue

Modern Approaches to Adipose Bedside Processing

Peter Rubin, MD, MBA (remotely)

Endowed Professor and Chair of Plastic Surgery, University of Pittsburgh

Micronized Adipose Tissue (mFAT) for the Treatment of Cartilage Defects

Jason L. Dragoo, MD, FAAOS

Professor and Vice Chair of Academic Affairs, Endowed Chair of Regenerative Medicine, University of Colorado

Bedside Utilization of Adipose Tissue Using Commercial System

David Pearce, PhD

President, Innovation and Research, Sanford Health

Clinical Trials of Autologous Cultured Cells for Cartilage Regeneration

Daniel B.F. Saris, MD, PhD

Professor of Regenerative Medicine, Mayo Clinic

Guided Cartilage Regeneration Using Skeletal Progenitor Cells

Charles KF Chan, PhD

Assistant Professor, Stanford University Stem Cell Institute

New Cartilage Restoration Technologies from the US and Europe

Jeffery M. Gimble, MD, PhD

Co-Founder, Artecel Sciences Inc, LaCell LLC, Obatala Sciences Inc and Talaria Antibodies Inc.

Session 3: Point of Care Processing of Autologous Blood Products

Moderator: Scott Rodeo, MD, FAAOS

Professor and Vice Chair of Research, Weill Medical College, Cornell University, Director, Center for Regenerative Medicine, Hospital for Special Surgery

Harnessing the Power of Peripheral Blood MSCs

Adam Anz, MD, FAAOS

Orthopedic Surgeon, Andrews Institute

Gene-modified Human Umbilical Vein Endothelial Cells (HUVEC) in Rotator Cuff Repair

Scott Rodeo, MD, FAAOS

Professor and Vice Chair of Research, Weill Medical College, Cornell University, Director, Center for Regenerative Medicine, Hospital for Special Surgery

Plasma Concentration of Alpha-2-Macroglobulin (A2M)

Gaetano J. Scuderi, MD

Founder, Cytonics Corporation

Production of Personalized Formulations of PRP

Xiaoning (Jenny) Yuan, MD, PhD

Assistant Professor and Vice Chair for Research, Department of PM&R, Uniformed Services University

Session 4: Future Directions of Biologics

Moderator: Jason L. Dragoo, MD, FAAOS

Professor and Vice Chair of Academic Affairs, Endowed Chair of Regenerative Medicine, University of Colorado

Dosed Autologous Products: USA

Robert J. Harman, DVM, MPVM

CEO/Founder of VetStem, Inc and Personalized Stem Cells, Inc.

Dosed Autologous Products: Europe

Frank Barry, PhD

Professor of Cellular Therapy, Regenerative Medicine Institute, University of Galway

Distributed Manufacturing of Cell Therapies for Orthopaedic Surgery

Dennis Powers, MS

Vice President, G-CON Manufacturing

Synergy Between Muscle Progenitor Cell and Bone Healing

Arnold Caplan, PhD

Professor and Director of the Skeletal Research Center, Case Western Reserve University

Future Directions Using Extracellular Vesicles (Exosomes)

Thomas Vangsness Jr, MD, FAAOS

Professor of Orthopaedic Surgery at the Keck School of Medicine of USC, Retired